Change of subgingival bacterial flora and level of drug concentration in gingiva of periodontal patients systemically administered azithromycin
スポンサーリンク
概要
- 論文の詳細を見る
Azithromycin is an azalide antibiotic, which has a strong effect on a wide variety of oral bacteria. It is taken up by phagocytes and is released over a long period in the inflamed tissue. This study investigated the clinical and microbiological effects, and measured the drug concentration in gingival of periodontal patients systemically administered azithromycin. The subjects were 26 adults diagnosed with periodontitis and given azithromycin (zithromac<SUP>®</SUP>) 500 mg once daily for 3 days. Clinical parameters such as PD, GI, BOP and GCF were examined at days 0, 7, and 14, and subgingival plaque was collected by paper points at days 0, 4, 7 and 14. The total number of cultivable bacteria was counted and six of the periodontopathic bacteria —<I>Porphyromonas gingivalis, Actinobacillus actinomysetemcomitans, Bacteroides forsythus, Prevotella intermedia, Prevotella nigresence, and Toreponema denticola</I>—were assessed by the PCR method. The lining gingiva of periodontal pocket was collected by pocket curettage at days 4 and 7. The azithromycin concentration was measured by agar diffusion bioassay.<BR>The total number of bacteria was significantly decreased at days 4 and 7, but was slightly increased at day 14. Continuous reduction of the six bacteria was recognized until day 14 by PCR. These bacteria were not detected at day 14 without <I>Porphyromonas gingivalis</I>. This result might be due to improvement of anaerobic condition caused by pocket reduction. The azithromycin concentration in the lining gingival tissues of periodontal pocket was 2.92±1.97μg/g at day 4 and 1.27±0.95μg/g at day 7. Half the drug concentration was still detected at 7 days after the first administration in inflamed gingiva.<BR>These results indicate that azithromycin may be a useful adjunct agent for adult periodontitis. In the future, we will consider a new periodontal therapy using this behavior of azithromycin.
- 日本歯科薬物療法学会の論文
日本歯科薬物療法学会 | 論文
- カンジダのバイオフィルム産生性に対する抗真菌薬の効果
- 当院における全身麻酔下手術中に使用された抗菌薬の15年間(1992-2006年)の推移
- 「顎骨骨髄炎に対する抗菌薬の効果判定基準」の解析結果
- 植物精油の口腔微生物に対する抗菌性およびバイオフィルム形成抑制効果の検討
- ニフェジピン歯肉増殖症患者の線維芽細胞に対する18α-グリチルレチン酸のアポトーシス誘導効果